Global Imbruvica Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 92

Report ID: 1073

Imbruvica is a small molecule drug that binds permanently to a protein, Bruton's tyrosine kinase (BTK), that is important in B cells; the drug is used to treat B cell cancers like mantle cell lymphoma, chronic lymphocytic leukemia, and Waldenström's macroglobulinemia.
In 2018, the global Imbruvica market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Imbruvica status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Imbruvica development in United States, Europe and China.

The key players covered in this study
AbbVie (Pharmacyclics)
Johnson & Johnson (Janssen Biotech)
SP Laboratories
...

Market segment by Type, the product can be split into
5 mg
10 mg
140 mg

Market segment by Application, split into
Mantle Cell Lymphoma
Chronic Lymphocytic Leukemia
Waldenström's Macroglobulinemia
Relapsed/Refractory Marginal Zone Lymphoma
Chronic Graft-Versus-Host-Disease

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Imbruvica status, future forecast, growth opportunity, key market and key players.
To present the Imbruvica development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Imbruvica are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Imbruvica Market Size Growth Rate by Type (2014-2025)
1.4.2 5 mg
1.4.3 10 mg
1.4.4 140 mg
1.5 Market by Application
1.5.1 Global Imbruvica Market Share by Application (2014-2025)
1.5.2 Mantle Cell Lymphoma
1.5.3 Chronic Lymphocytic Leukemia
1.5.4 Waldenström's Macroglobulinemia
1.5.5 Relapsed/Refractory Marginal Zone Lymphoma
1.5.6 Chronic Graft-Versus-Host-Disease
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Imbruvica Market Size
2.2 Imbruvica Growth Trends by Regions
2.2.1 Imbruvica Market Size by Regions (2014-2025)
2.2.2 Imbruvica Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Imbruvica Market Size by Manufacturers
3.1.1 Global Imbruvica Revenue by Manufacturers (2014-2019)
3.1.2 Global Imbruvica Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Imbruvica Market Concentration Ratio (CR5 and HHI)
3.2 Imbruvica Key Players Head office and Area Served
3.3 Key Players Imbruvica Product/Solution/Service
3.4 Date of Enter into Imbruvica Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Imbruvica Market Size by Type (2014-2019)
4.2 Global Imbruvica Market Size by Application (2014-2019)

5 United States
5.1 United States Imbruvica Market Size (2014-2019)
5.2 Imbruvica Key Players in United States
5.3 United States Imbruvica Market Size by Type
5.4 United States Imbruvica Market Size by Application

6 Europe
6.1 Europe Imbruvica Market Size (2014-2019)
6.2 Imbruvica Key Players in Europe
6.3 Europe Imbruvica Market Size by Type
6.4 Europe Imbruvica Market Size by Application

7 China
7.1 China Imbruvica Market Size (2014-2019)
7.2 Imbruvica Key Players in China
7.3 China Imbruvica Market Size by Type
7.4 China Imbruvica Market Size by Application

8 Japan
8.1 Japan Imbruvica Market Size (2014-2019)
8.2 Imbruvica Key Players in Japan
8.3 Japan Imbruvica Market Size by Type
8.4 Japan Imbruvica Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Imbruvica Market Size (2014-2019)
9.2 Imbruvica Key Players in Southeast Asia
9.3 Southeast Asia Imbruvica Market Size by Type
9.4 Southeast Asia Imbruvica Market Size by Application

10 India
10.1 India Imbruvica Market Size (2014-2019)
10.2 Imbruvica Key Players in India
10.3 India Imbruvica Market Size by Type
10.4 India Imbruvica Market Size by Application

11 Central & South America
11.1 Central & South America Imbruvica Market Size (2014-2019)
11.2 Imbruvica Key Players in Central & South America
11.3 Central & South America Imbruvica Market Size by Type
11.4 Central & South America Imbruvica Market Size by Application

12 International Players Profiles
12.1 AbbVie (Pharmacyclics)
12.1.1 AbbVie (Pharmacyclics) Company Details
12.1.2 Company Description and Business Overview
12.1.3 Imbruvica Introduction
12.1.4 AbbVie (Pharmacyclics) Revenue in Imbruvica Business (2014-2019)
12.1.5 AbbVie (Pharmacyclics) Recent Development
12.2 Johnson & Johnson (Janssen Biotech)
12.2.1 Johnson & Johnson (Janssen Biotech) Company Details
12.2.2 Company Description and Business Overview
12.2.3 Imbruvica Introduction
12.2.4 Johnson & Johnson (Janssen Biotech) Revenue in Imbruvica Business (2014-2019)
12.2.5 Johnson & Johnson (Janssen Biotech) Recent Development
12.3 SP Laboratories
12.3.1 SP Laboratories Company Details
12.3.2 Company Description and Business Overview
12.3.3 Imbruvica Introduction
12.3.4 SP Laboratories Revenue in Imbruvica Business (2014-2019)
12.3.5 SP Laboratories Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details